BIOHAVEN PHARMACEUTICALS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 90788388
Serial Number
90788388
Registration Number
6629316
Word Mark
BIOHAVEN PHARMACEUTICALS
Status
700 - Registered
Status Date
2022-01-25
Filing Date
2021-06-22
Registration Number
6629316
Registration Date
2022-01-25
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
010905, 261502, 261513 - Atoms or molecular models. Plain single or multiple line polygons. More than one polygon.
Published for Opposition Date
2021-11-09
Attorney Name
Monica Riva Talley
Law Office Assigned Location Code
M20
Employee Name
CLIFFORD, MEGAN NICOLE
Statements
Disclaimer with Predetermined Text
"PHARMACEUTICALS"
Description of Mark
The mark consists of the stylized wording "BIOHAVEN PHARMACEUTICALS", with two outlined hexagon shapes positioned above the letter "I" and one outlined hexagon shape positioned below the letter "I", and the wording "PHARMACEUTICALS" appearing in smaller print below the wording "BIOHAVEN".
Goods and Services
Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post- intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in Amyotrophic Lateral Sclerosis (ALS), pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in Alzheimer's disease (AD), disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine for the adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use
Goods and Services
Pharmaceutical research and development in the fields of headache, facial pain, impulse control disorders, neurological disorders, and neurodegenerative disorders, and consultation provided in conjunction therewith
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-09-07
Primary Code
005
First Use Anywhere Date
2020-03-00
First Use In Commerce Date
2020-03-00
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-09-07
Primary Code
042
First Use Anywhere Date
2013-09-00
First Use In Commerce Date
2013-09-00
Current Trademark Owners
Party Name
Biohaven Therapeutics Ltd.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Biohaven Therapeutics Ltd.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Biohaven Therapeutics Ltd.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Biohaven Therapeutics Ltd.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Monica Riva Talley
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0117307
Original Filing Date USPTO
2021-12-14
International Status Code
403
Madrid History Events
DateCodeDescription
2021-12-14NEWAPNEW APPLICATION FOR IR RECEIVED
2021-12-16MCERTMANUALLY CERTIFIED
2021-12-16APPSTIR CERTIFIED AND SENT TO IB
Trademark Events
Event DateEvent Description
2021-06-25NEW APPLICATION ENTERED IN TRAM
2021-09-07NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-09-08NOTICE OF DESIGN SEARCH CODE E-MAILED
2021-09-08ASSIGNED TO EXAMINER
2021-09-10NON-FINAL ACTION WRITTEN
2021-09-10NON-FINAL ACTION E-MAILED
2021-09-10NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-09-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-09-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-09-21TEAS/EMAIL CORRESPONDENCE ENTERED
2021-10-06APPROVED FOR PUB - PRINCIPAL REGISTER
2021-10-20NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-11-09PUBLISHED FOR OPPOSITION
2021-11-09OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2022-01-12ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
2022-01-25REGISTERED-PRINCIPAL REGISTER